Teen To Graduate, Despite Fatal Disease PDF Print E-mail
Wednesday, 09 June 2010 09:07
A rare and life threatening medical disorder has kept a Portsmouth teen out of school and unable to walk for months, but Wednesday night he will walk the stage at his graduation. Wednesday night, families will be filing into the N-Telos pavilion in Portsmouth to celebrate the graduation of Churchland High School's class of 2010, and all they've accomplished over the past four years.

But what one student accomplished over the past four weeks might just leave them in awe. "I feel good that I'm still alive," said Jawuan Trotter, who was diagnosed with Scleroderma. While his Churchland classmates have been busy planning new lives, in January Jawuan Trotter was planning for his death.

"I was thinking of my own will in my head; it was a hard time," he said. It was almost unimaginable for the confident teen, who was voted homecoming prince. "We started to notice his hands became very thick and leather like," said Jawuan's mother Desiree Trotter.

His doctor diagnosed him with Scleroderma.

"We had never heard of it," his mother said. "We didn't know what it was, didn't know how to spell it, but she asked us not to look online, because Scleroderma is often deadly and rarely diagnosed in children.

"I think this may be the first patient we've had on our inpatient rehab unit," said Dr. Jean Shelton. She says Scleroderma is an auto-immune disorder; Jawuan's immune system is essentially attacking his own body. "In his case, [the disease] attacks the brain, the spinal chord, as well as the soft tissues, the hands and the arms and throughout the body," Shelton said.

It got so bad, Jawuan could not stand for more than five seconds.

"When I couldn't go to school anymore it was depressing, very depressing," said Jawuan. He started working with therapists at Children's Hospital of the King's Daughters in April. But come Wednesday, it'ill be worth it. "He's graduating with a 3.38 advanced honors diploma," said Desiree Trotter. "That's awesome."

Source: Wavy.com
 
More articles :

» The Scleroderma Foundation Teams Up with Traitwise

The has teamed up with Austin, TX company, Incorporated, to launch a unique survey to poll thousands of patients and their caregivers. Data from the survey will be shared with researchers nationally and internationally in an effort to improve...

» A System Out of Breath: How Hypoxia Possibly Contributes to the Pathogenesis of Systemic Sclerosis

T. W. van Hal, L. van Bon, and T. R. D. J. RadstakeReceived 20 May 2011; Revised 18 August 2011; Accepted 7 September 2011Systemic sclerosis (SSc) is typified by vascular alterations and immunological disturbances and fibrosis of the skin and...

» Cancer Drug Shows Promise For Treating Scleroderma

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with , according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold...

» Therapies for Scleroderma-related Pulmonary Arterial Hypertension

Paul M. HassounPosted: 08/20/2009; Expert Rev Resp Med. 2009;3(2):187-196. © 2009 Expert Reviews Ltd.Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading...

» Unite Against Scleroderma A Great Success

Our very first Scleroderma Awareness Walk, "Unite Against Scleroderma" was a great success. Sunday May 1st was a dream that became a reality, simply because family and friends of the Foundation also wanted the community of Trinidad and Tobago to be...

» New Research Findings May Bring Breakthrough For Scleroderma Patients

Research presented at the European Academy of Dermatology and Venereology in Prague, Czech Republic, suggests that inhibition of the may be a viable therapeutic target in patients.This finding builds on previous research by presenter and lead...